Dr. Christine Günther has been Chief Executive Officer, Chief Medical Officer and Qualified Person at apceth Biopharma since 2008 (then apceth). She is a specialist in clinical hematology and oncology with extensive experience in clinical stem cell transplantation, transplantation immunology and cell therapies. Her particular area of expertise is pharmaceutical development of complex cell-based and gene therapy products.
Before joining apceth, Christine Günther worked as qualified person, head of quality control and medical director at the German public stem cell and cord blood bank. Her work there focused on stem cell and tissue procurement, donor testing and characterization of cell products – including cord blood products – and their application to the patient in the treatment of malignant diseases. Before that she gained extensive experience as a hematologist/oncologist at the University Hospital in Munich, Germany.
Dusan Kosijer has served as Chief Financial Officer of apceth since October 2016. Prior to joining apceth, Mr. Kosijer served as CFO for Accovion GmbH, a Contract Research Organization (CRO) headquartered close to Frankfurt. Throughout his career, he has gained more than 14 years’ experience in the healthcare sector. Mr. Kosijer is Certified Management Accountant by training.
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.